Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Procyon Biopharma Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Tim Cruise who wrote (144)	8/13/1999 8:45:00 AM
From: Ian@SI	Read Replies (1) \| Respond to of 356

Tim, No, I won't mark my daytimer. To bring a new treatment through to NDA takes large 10s of Millions to small 100s of millions. Procyon won't do this without a treatment that has at least passed Phase 1 trials, has a partner with deep pockets, and a disease for which there currently is no alternative that leads to a satisfactory outcome. Wanting a company to succeed is often much different than the prerequisite conditions for success. I'll hold my QLT for a very long time unless its story changes. Good luck trading Procyon. Ian